This inventor holds 1 USPTO granted patent. Top assignees: Tessa Therapeutics Pte. Ltd, The University of North Carolina at Chapel Hill. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3 
1 out of 1,330 
Years Active: 2026
Title: Aung Myo: Innovator in Cancer Treatment
Introduction
Aung Myo is a notable inventor based in Singapore, recognized for his contributions to the field of cancer treatment. He has developed innovative solutions aimed at addressing complex medical challenges, particularly in oncology.
Latest Patents
Aung Myo holds a patent for the "Treatment of CD30-Positive Cancer." This patent represents a significant advancement in the therapeutic approaches available for treating this specific type of cancer, showcasing his commitment to improving patient outcomes.
Career Highlights
Throughout his career, Aung Myo has worked with esteemed organizations, including Tessa Therapeutics Pte. Ltd and The University of North Carolina at Chapel Hill. His experiences in these institutions have allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Aung Myo has collaborated with Ivan David Horak, further enhancing his research and development efforts in cancer treatment. Their partnership exemplifies the importance of teamwork in advancing medical innovations.
Conclusion
Aung Myo's work in cancer treatment, particularly with his patent on CD30-positive cancer, highlights his role as a significant innovator in the medical field. His collaborations and career achievements reflect his dedication to improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile